Internal Medicine, Hematology & Oncology · Beverly Hills, CA
NPI
1104822600
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
9090 Wilshire Blvd, Ste 200
Beverly Hills, CA, 90211
Phone (310) 888-8680
Groups this clinician bills Medicare through
Medicare paid, 2024
$279K
14,720 services
Medicare patients, 2024
703
Average age 75
Drug cost, 2024
$2.9M
741 prescriptions
Company payments, 2025
$65.14
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Philomena F McAndrew was code J9395 (injection, fulvestrant, 25 mg), 4,160 times for 26 patients. In total Philomena F McAndrew billed 14,720 services in 58 codes, and Medicare paid $279K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-04-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9395 Injection, fulvestrant, 25 mg | Office | 4,160 | 26 | $6.15 | $26K |
| 99214 Office E&M - Established | Office | 702 | 460 | $99.91 | $70K |
| 36415 Venipuncture Blood Collection | Office | 517 | 290 | $8.65 | $4,472 |
| 96402 Chemotherapy Administration | Office | 407 | 27 | $31.18 | $13K |
| 99213 Office E&M - Established | Office | 404 | 305 | $65.92 | $27K |
| 99215 Office E&M - Established | Office | 253 | 170 | $143.88 | $36K |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 89 | 50 | $27.36 | $2,435 |
| 96372 Injection Administration | Office | 79 | 19 | $12.07 | $954 |
| 96361 Intravenous Infusion, Hydration | Office | 52 | 11 | $9.82 | $511 |
| 99205 Office E&M - New | Office | 49 | 49 | $184.61 | $9,046 |
| 99233 Hospital E&M - Subsequent | Facility | 19 | 12 | $93.09 | $1,769 |
| 99443 Telephone Services | Office | 15 | 14 | $111.61 | $1,674 |
By year: 2022 $341K for 18,972 services; 2023 $309K for 14,651 services; 2024 $279K for 14,720 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 517 | 290 | $8.65 | $4,472 |
Medicare prescription drug claims, 2024
In 2024, the drug Philomena F McAndrew prescribed most often to Medicare patients was Anastrozole, with 94 prescriptions and refills. In total Philomena F McAndrew wrote 741 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 94 | 161 | 26 | $972 |
| Exemestane Generic | 84 | 114 | 28 | $8,613 |
| Letrozole Generic | 81 | 129 | 30 | $1,005 |
| Kisqali Ribociclib Succinate | 73 | 73 | 12 | $1.1M |
| Estradiol Generic | 46 | 89 | 17 | $4,549 |
| Alendronate Sodium Generic | 36 | 55 | Under 11 | $44.01 |
| Tamoxifen Citrate Generic | 31 | 54 | 14 | $689 |
| Raloxifene Hcl Generic | 24 | 37 | 11 | $701 |
| Verzenio Abemaciclib | 24 | 24 | Under 11 | $354K |
| Truqap Capivasertib | 15 | 15 | Under 11 | $328K |
| Gabapentin Generic | 14 | 24 | Under 11 | $98.97 |
| Xarelto Rivaroxaban | 13 | 13 | Under 11 | $7,343 |
| Ibrance Palbociclib | 13 | 13 | Under 11 | $193K |
| Braftovi Encorafenib | 12 | 12 | Under 11 | $171K |
| Imbruvica Ibrutinib | 12 | 12 | Under 11 | $141K |
Brand drugs: 226 claims; generic drugs: 515 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Philomena F McAndrew $65.14 ($65.14 in general payments such as food, travel and fees) from 2 companies. The largest payer was Genzyme Corporation with $39.17.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.